Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP): a study protocol

INTRODUCTION: Chronic pain is prevalent, and approximately half of patients with chronic pain experience sleep disturbance. Exogenous melatonin is licensed to treat primary insomnia and there is some evidence for analgesic effects of melatonin. The aim of this study is to investigate the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam, Rosalind, Kanakarajan, Saravanakumar, Onyeakazi, Uzunma, Columb, Malachy, Galley, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Anaesthesia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076250/
https://www.ncbi.nlm.nih.gov/pubmed/32184313
http://dx.doi.org/10.1136/bmjopen-2019-034443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076250/
https://www.ncbi.nlm.nih.gov/pubmed/32184313
http://dx.doi.org/10.1136/bmjopen-2019-034443

Ejemplares similares